Article Details

Pfizer/Myovant take relugolix contraceptive combination pill into phase 3

Retrieved on: 2021-04-14 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

Pfizer/Myovant take relugolix contraceptive combination pill into phase 3. View article details on hiswai:

Excerpt

Pfizer and Myovant have begun a late-stage trial of their potential uterine fibroid drug relugolix, as part of a contraceptive combination tablet. The FDA ...

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up